Bioventus (BVS) Non-Current Debt (2020 - 2026)

Bioventus' Non-Current Debt history runs 7 years deep, the most recent figure standing at $253.3 million for Q1 2026.

• Quarterly Non-Current Debt fell 17.91% year-over-year to $253.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.3 million (down 17.91% YoY) and the FY2025 annual result came in at $279.0 million, down 9.52% from the prior year.
• Non-Current Debt was $253.3 million for Q1 2026 at Bioventus, down from $279.0 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $404.3 million in Q2 2023 and bottomed at $253.3 million in Q1 2026.
• A 5-year average of $341.3 million and a median of $348.0 million in 2022 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2022 — Non-Current Debt jumped 142.0% — and 2026, when it dropped 17.91%.
• Bioventus' Non-Current Debt stood at $385.0 million in 2022, then fell by 4.68% to $367.0 million in 2023, then dropped by 16.0% to $308.3 million in 2024, then dropped by 9.52% to $279.0 million in 2025, then decreased by 9.19% to $253.3 million in 2026.
• Business Quant data shows BVS's Non-Current Debt at $253.3 million in Q1 2026, $279.0 million in Q4 2025, and $311.3 million in Q3 2025.